We have initiated a position in Quest Resource Holding (QRHC). Quest is an interesting combination of a turnaround play at the point of having bottomed and starting to head higher, combined with a nice secular growth story. The value here...
My Take on The Market This was a good week in the market, which was a welcome relief. We had a big bailout announced by the federal government and some estimates of how bad COVID19 could be came down a...
Although I was aware of the trend towards E.S.G investing, I didn't understand the true magnitude of it until the recent action in Tesla.  Lots of people tell me that Tesla went up on its own and that E.S.G....
Tailwinds' Take: the implications of this study are potentially massive. It truly appears that NR has many positive effects and is well on its way to becoming a blockbuster supplement. No side effects, many benefits. There appears to be...
Greetings from Stresa Italy, a gorgeous town on the edge of Lake Maggiore. With great food, excellent wines and friendly people, Italy is always a great place to relax. This is especially true during times of market weakness, as...
Tailwinds' Take: a small beat, as expected. Margins low, but due primarily to investing in growth, so like that answer. Longer term targets for 2023 reflect strong growth and very bullish. Management is competent and confident. All good here. MEDFORD,...
As of this morning, at $2.09 per share, we have added Cryoport (CYRX) to the Tailwinds Select Portfolio. Cryoport is in the business of shipping medicines. Any biologic that needs to be cryogenically suspended until it is dosed into a...
Tailwinds' Take: Not a surprise that Jaksch moves out of the CEO role as this morphs into a consumer company. Fried is an experienced professional who is capable of driving CDXC into a billion dollar company. IRVINE, Calif., April 23, 2018 (GLOBE...
Last week I had the opportunity to drop in on Catasys' offices in LA and meet up with Christopher Shirley, their CFO. Christopher has been with the Company for close to a year, having come over from GE. We...
IRVINE, Calif., June 19, 2017 /PRNewswire/ -- The Cryoport Biotech Activity Index (the "CoBRA IndexSM") quantifies the activity in the development and clinical trials of regenerative therapies in the United States, and acts as a means by which investors, the media...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.